Amyloid-beta protein – the primary constituent of the plaques found in the brains of Alzheimer's disease patients – may be part of the body's first-line system to defend against infectionIn their report in the March 3 issue of the open-access journal PLoS One, a team led by Massachuset

read more>>

The Batten Disease Support and Research Association (BDSRA) is pleased to announce that limited funds are available to promote research and/or assist in a viable research project/s primarily for, but not limited to, development of novel therapeutic approaches to treatment for NCL, including the Al

read more>>

The first systematic study of surveillance techniques for the insect vector of Chagas disease in Amazonia, conducted by researchers from the Fiocruz Instituto Leônidas e Maria Deane, the Smithsonian Tropical Research Institute, the London School of Hygiene and Tropical Medicine and colleagues

read more>>

Researchers at the Vanderbilt Eye Institute are now a step closer to deciphering a leading cause of blindness in the United States – glaucomaIn a recent study, David Calkins, Ph.D., director of Research at the VEI, discovered that the first sign of injury in glaucoma actually occurs in the b

read more>>

Alzheimer's disease affects an estimated 27 million people worldwideIt is the most common form of age-related dementia, possibly the most feared disease of old age. There is no cure, and the available drugs only help to relieve symptoms without slowing progression of the disease. One of the charac

read more>>

A recent study found that rats with advanced fibrosis that were administered a short-term dose of losartan-M6PHSA had reduced liver inflammation and fibrosisThose animals treated with oral losartan alone did not experience a similar reduction in disease activity. Results of this study appear in th

read more>>

Spanish researchers determined that rats treated with recombinant ghrelin displayed a reduction in liver fibrosisGhrelin, a stomach hormone, reduced the amount of fibrogenic cells by 25% in the treated rodents. Research further showed ghrelin prevented acute liver damage and reduced oxidative stre

read more>>

A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchersThe findings, published in the March issue of Gastroenterology, could help personalize treatments

read more>>

COLUMBUS, Ohio -- Reversing a protein deficiency through gene therapy can correct motor function, restore nerve signals and improve survival in mice that serve as a model for the lethal childhood disorder spinal muscular atrophy, new research showsThis muscle-wasting disease results when a child&r

read more>>

A new study published on bmj.com today casts doubt on recent claims that a human retrovirus known as XMRV is linked to chronic fatigue syndrome or ME (myalgic encephalitisThis is the third study to refute the original US study reporting the linkChronic fatigue syndrome is a debilitating condition

read more>>